Liver |
LO2 HepG2 Hep3B |
Apoptosis induction & angiogenesis inhibition
|
in vitro in vivo |
[47] |
Liver |
SK-Hep1 |
Anti-tumor progression through suppressing STAT3 and NF-kB
suppresses cell-matrix adhesion, cell motility and cell invasion at non-cytotoxic concentration
increases the expression of E-cadherin and decreases the expression of vimentin and α2-, α6-, β1-integrin
|
in vitro in vivo |
[34] |
Lung |
A549 |
Apoptosis induction & cell migration suppression
induces apoptosis by loss of mitochondrial function and increases the antioxidant activities by up-regulation of SOD
inhibits the invasion and migration by down-regulation of COX2 and VEGF at the transcription level
|
in vitro |
[52] |
Lung |
H1299 H460 H292 |
Apoptosis induction by suppression of EGFR/STAT3 activation
inhibits phosphorylation of EGFR and STAT3 and shows potential to treat advanced NSCLC with acquired resistance to EGFR tyrosine kinase inhibitor
The docking analysis: morusin directly binds to the tyrosine kinase domain of EGFR
|
in vitro |
[14] |
Breast |
MCF-10A 4T1 MCF-7 |
Suppression of cancer cell growth through C/EBPβ- and PPARγ-mediated lipoapoptosis
inhibits human breast cancer cell proliferation and increases the expression of C/EBPβ, PPARγ, adipsin D and perilipin
induces adipogenic differentiation, apoptosis and lipoapoptosis of cancer cells
|
in vitro in vivo |
[65] |
Breast |
MCF-10A MCF-7 MDA-MB231 |
Apoptosis induction
The apoptosis marker proteins, cleaved caspase-3 and caspase-9 were consistently upregulated
suppresses the expression of the anti-apoptotic Survivin and induces pro-apoptotic Bax expression
|
in vitro |
[51] |
Brain |
U87 GI-1 HCN-1A |
Morusin-loaded nanoparticles for targeted glioblastoma therapy
Morusin was loaded in chlorotoxin-modified PLGA nanoparticles which target chloride channels and MMP-2 in glioma tumor cells
Morusin-loaded nanoparticles inhibit growth of U87 and GI-1 glioma cells by ROS generation, enhanced caspase activity, cytoskeletal destabilization and inhibition of MMP activity
|
in vitro |
[89] |
Brain |
WJ1 WJ2 |
Inhibition of glioblastoma stem cell growth through stemness attenuation, adipocyte transdifferentiation
increases adipogenic markers, such as PPARγ, adipsin D, aP2 and perilipin and induces apoptosis
reduces stemness of GSCs by inhibition of the expression of stemness markers (CD133, nestin, Sox2 and Oct4)
|
in vitro in vivo |
[39] |
Brain |
U251MG LN18 U87MG |
TRAIL sensitization by regulating EGFR and DR5 in human glioblastoma cells
Combinatorial treatment of TRAIL with morusin synergistically decreased cell viability and increased apoptosis
induces the expression of DR5 and decreases anti-apoptotic survivin and XIAP by reduced expression of EGFR and pSTAT3
|
in vitro |
[38] |
Skin |
JB6 P+ |
Blocking TPA-induced malignant transformation of mouse epidermal cells
reduces the TPA-induced ROS production, AP1 and NF-κB in JB6 P+ cells at non-cytotoxic concentration
decreases TPA-upregulation of COX-2, N-cadherin and Vimentin
|
in vitro |
[45] |
Stomach |
MKN45 SGC7901 |
Inhibition of cell proliferation and tumor growth by down-regulating c-Myc
suppresses tumor growth and down-regulates CDKs and cyclins, such as CDK2, CDK4, cyclin D1 and cyclin E1.
reduces the expression of c-Myc and c-Myc protein binding at the E-Box regions
|
in vitro in vivo
|
[90] |
Pancreas |
AsPC-1 BxPC-3 MIAPaCa-2 PANC-1 |
Apoptosis induction and inhibition of invasion by blockage of STAT3 signaling pathway
inhibits STAT3 activation and suppresses activation of upstream JAK1, JAK2 and c-Src kinases.
arrest cell cycle at G1/G0 or G2/M phase and causes induction of apoptosis and loss of mitochondrial membrane potential
|
in vitro |
[48] |
Bone |
U2OS HOS |
Inhibition of human osteosarcoma via PI3K-AKT signaling pathway
|
in vitro |
[55] |
Ovary |
A2780 SKOV-3 HO-8910 |
Paraptosis-like cell death induction through mitochondrial calcium overload and dysfunction
causes mitochondrial Ca2+ influx and induces paraptosis-like cell death via mitochondrial Ca2+ overload
increases ROS and decreases mitochondrial membrane potential and inhibits the growth of SKOV-3 xenograft in nude mice
|
in vitro in vivo |
[37] |
Prostate |
DU145 PC-3 LNCaP RWPE-1 |
Cell death induction through inactivating STAT3 signaling
reduces STAT3 activity by suppressing kinase activities of JAK2 and Src and increases SHP1 phosphatase activity
down-regulates the expression of STAT3 target genes encoding Bcl-xL, Bcl-2, Survivin, c-Myc and cyclin D1
|
in vitro |
[36] |
Cervix |
HeLa |
Apoptosis induction & inhibition of human cervical cancer stem cell growth and migration through attenuation of NF-κB activity
decreases the proliferation, tumor sphere formation and migration of human cervical CSCs and increases apoptosis
decreases the expression levels of NF-κB/p65 and Bcl-2, while increases expression levels of Bax and caspase-3
|
in vitro |
[40] |
Kidney |
769-P 786-O OSRC-2 |
Anti-cancer activity by disturbing MAPK signaling pathways
inhibits cell growth and migration, induces cell apoptosis and induces the cell cycle arrest in the G1 phase
up-regulates P-p38 and P-JNK levels, while the down-regulates P-ERK level
|
in vitro in vivo |
[54] |
Liver Spleen |
H22 |
Inhibition of transplanted H22 hepatocarcinoma
inhibits the tumor growth of transplanted H22 hepatocarcinoma in mice by reducing the expression of NF-κB
increases the expression of p53, Survivin, cyclin B1 and caspase-3
|
in vitro in vivo |
[46] |
Colon Liver Breast |
HT-29 Hep3B MCF-7 |
Apoptosis induction & suppression of NF-κB activity
inhibits the phosphorylation of IKK-α, IKK-β and IκB-α and suppresses NF-κB nuclear localization and its DNA binding
causes activation of caspase-8, change of mitochondrial membrane potential, release of Cytochrome c and Smac/DIABLO and activation of caspase-9 and caspase-3
|
in vitro |
[35] |
Cervix Breast Bone |
HeLa U2OS ZR75B |
Attenuation of RACK1-mediated apoptotic cell death by stress granule (SG) formation
|
in vitro |
[74] |
Cervix Breast Bone Colon |
HeLa MCF-7 U2OS HCT116 |
Autophagy induction inhibits cell death
induces AMPK activation and inhibits mTOR activity, resulting in LC3-II accumulation and ULK1 activation for autophagy
autophagy induction is an impediment for morusin-induced apoptosis
|
in vitro |
[68] |